Elevated free FAs present in the plasma of patients with type 2 diabetes or insulin resistance [31] and higher glucose concentrations could lead to less effective recovery of the HSA-SH content in these individuals during the half-life of HSA [21,27]. The gene discussed is ALB; the disease is type 2 diabetes mellitus.